← SynDRA
NEPAFENAC
SynDRA canonical compound SYN0003197 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
| Indication | eye inflammation |
|---|
| Disease area | ophthalmology |
|---|
All known targets
- PTGS1
- PTGS2
- PTGS1; PTGS2
- Ptgs1
- Ptgs2
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- PTGS2 INHIBITOR
- PTGS1 INHIBITOR
- Inhibitor
Drug classes
- Cyclooxygenase Inhibitors
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
- Nonsteroidal Anti-inflammatory Drug
ATC classes
- S01B · ANTIINFLAMMATORY AGENTS
Cross-references
Synonyms
- nevanac
- Nepafenaco
- AHR-9434
- AL-6515
- Ilevro
- Nevanac
- Amfenac
- 2-(2-amino-3-benzoylphenyl)acetic acid
- Amfenaco
- Amfenacum
- (2-Amino-3-benzoylphenyl)acetic acid
- (2-Amino-3-benzoylphenyl)essigsaeure
- CHEBI:75915
- NSC 309467
- 28O5C1J38A
- Amfenac (INN)
- AMFENAC [INN]
- AHR-5850D
- Amfenac [INN:BAN]
- Amfenacum [INN-Latin]
- Amfenaco [INN-Spanish]
- UNII-28O5C1J38A
- Fenazox (Japan)
- 2-amino-3-benzoylbenzeneacetic acid
- 2-Amino-3-Benzoylphenylacetic Acid
- AMFENAC [MI]
- AMFENAC [WHO-DD]
- SCHEMBL24249
- ZINC909
- CHEMBL25146
- GTPL7565
- DTXSID90199533
- BDBM50225110
- MFCD00866133
- NSC309467
- 2-(2-amino-3-benzoylphenyl)aceticacid
- SY265113
- 2-[2-amino-3-(benzoyl)phenyl]acetic acid
Look up NEPAFENAC in the interactive SynDRA portal →